MR扩散加权成像早期诊断前列腺癌的临床应用价值探讨  

Exlporation of the clinical application value of MR diffusion weighted imaging in the early diagnosis of prostate cancer

作　　者：孙海林[1] Sun Hailin(MRI Room,People’s Hospital of Sheyang County,Yancheng 224300,China)

机构地区：[1]射阳县人民医院MRI室,江苏盐城224300

出　　处：《江苏科技信息》2021年第4期59-61,共3页Jiangsu Science and Technology Information

摘　　要：目的:探究分析在前列腺癌早期诊断中采取MR扩散加权成像诊断的效果。方法:分别从2018年11月至2020年11月射阳县人民医院收治的前列腺癌患者和前列腺增生患者中抽选35例,前列腺癌患者列为实验组,前列腺增生患者列为对照组,所有患者均接受MR扩散加权成像检查,对比两组临床诊断结果。结果:MR扩散加权成像诊断在前列腺癌诊断准确率(93.02%)、前列腺增生诊断准确率(96.08%)均与病理诊断(100.00%、100.00%)差异无统计学意义(P>0.05);前列腺癌患者病灶ADC值明显低于前列腺增生患者,差异具有统计学意义(t=12.055,P<0.05)。结论:在前列腺癌早期诊断中采取MR扩散加权成像诊断能够很好地诊断和辨别疾病,临床应用价值较高,值得推广应用。Objective:To explore and analyze the effect of MR diffusion weighted imaging in the early diagnosis of prostate cancer.Methods:35 prostate cancer patients and benign prostatic hyperplasia patients who were admitted from November 2018 to November 2020 were selected respectively.Prostate cancer patients were listed as the experimental group,and prostate hyperplasia patients were listed as the control group.All patients received MR diffusion weighted imaging examination to compare the clinical diagnosis results of the two groups.Results:(1)The diagnostic accuracy of MR diffusion-weighted imaging in the diagnosis of prostate cancer(93.02%)and the diagnostic accuracy of benign prostatic hyperplasia(96.08%)were not statistically different from the pathological diagnosis(100.00%,100.00%)(P>0.05);(2)The ADC value of lesions in cancer patients was significantly lower than that of patients with prostate hyperplasia,and the difference was statistically significant(t=12.055,P<0.05).Conclusion:In the early diagnosis of prostate cancer,MR diffusion weighted imaging can be used to diagnose and distinguish the disease.It has high clinical application value and is worthy of promotion and application.

关 键 词：MR扩散加权成像 早期诊断 前列腺癌 

分 类 号：R8[医药卫生—临床医学]